Bio-Rad Laboratories (NYSE:BIO.B) Sets New 12-Month Low at $268.80

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) reached a new 52-week low during trading on Tuesday . The company traded as low as $268.80 and last traded at $268.95, with a volume of 135 shares. The stock had previously closed at $279.91.

Bio-Rad Laboratories Stock Performance

The stock has a market capitalization of $7.67 billion, a PE ratio of -13.03 and a beta of 0.66. The business has a 50 day moving average price of $326.03 and a 200 day moving average price of $316.86. The company has a debt-to-equity ratio of 0.14, a current ratio of 5.83 and a quick ratio of 4.34.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Thursday, February 15th. The company reported $3.10 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 23.86%. The firm had revenue of $681.18 million for the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.